Immunotherapy for pancreatic cancer: A long and hopeful journey
Multiple therapeutic strategies have been developed to treat pancreatic cancer. However, the outcomes of these approaches are disappointing. Due to deeper understandings of the pivotal roles of the immune system in pancreatic cancer tumorigenesis and progression, novel therapeutic strategies based on immune cells and the tumor microenvironment are being investigated. Some of these approaches, such as checkpoint inhibitors, chimeric antigen receptor T-cell therapy, and BiTE antibodies, have achieved exciting outcomes in preclinical and clinical trials.
Source: Cancer Letters - Category: Cancer & Oncology Authors: Jian-wei Xu, Lei Wang, Yu-gang Cheng, Guang-yong Zhang, San-yuan Hu, Bin Zhou, Han-xiang Zhan Tags: Mini-review Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Immunotherapy | Pancreas | Pancreatic Cancer